跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PHARMORIX LEVUN3 CAPSULE - NPRA Drug Approval Details
Approvals
/
NPRA
/
PHARMORIX LEVUN3 CAPSULE
Approved
STANDARD
PHARMORIX LEVUN3 CAPSULE
PHARMORIX (M) SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Sep 10, 2026
Approval ID
c76880b3eacf4939
Company
PHARMORIX (M) SDN. BHD.
Type
Standard
Approval Details
Approval Id
c76880b3eacf4939
Drug Approval Npra Name
PHARMORIX LEVUN3 CAPSULE
Product Name
PHARMORIX LEVUN3 CAPSULE
Registration Number
MAL26096046TC
Holder Company Name
PHARMORIX (M) SDN. BHD.
Holder Address
SUITE 163E, LEVEL 16, HUNZA TOWER GURNEY PARAGON, JALAN KELAWEI, 10250 GEORGETOWN MALAYSIA
Holder Phone
0199809298
Manufacturer Company Name
BELIVE HEALTHCARE SDN. BHD.
Manufacturer Address
NO. 1 JALAN PENYAJAK U1/45A TAMAN PERINDUSTRIAN TEMASYA ALPINE, SEKSYEN U1 40150 SHAH ALAM MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL26096046TC
Version
1789067438
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Sep 10, 2026
Approval ID
c76880b3eacf4939
Type
Standard
Source
Official Source
Back to NPRA Approvals